JP2022535743A5 - - Google Patents

Info

Publication number
JP2022535743A5
JP2022535743A5 JP2021570361A JP2021570361A JP2022535743A5 JP 2022535743 A5 JP2022535743 A5 JP 2022535743A5 JP 2021570361 A JP2021570361 A JP 2021570361A JP 2021570361 A JP2021570361 A JP 2021570361A JP 2022535743 A5 JP2022535743 A5 JP 2022535743A5
Authority
JP
Japan
Prior art keywords
alkyl
independently selected
group
substituted
ring
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2021570361A
Other languages
English (en)
Japanese (ja)
Other versions
JP2022535743A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2020/035249 external-priority patent/WO2020243519A1/en
Publication of JP2022535743A publication Critical patent/JP2022535743A/ja
Publication of JP2022535743A5 publication Critical patent/JP2022535743A5/ja
Pending legal-status Critical Current

Links

JP2021570361A 2019-05-29 2020-05-29 Sting活性に関連する状態を治療するための化合物および組成物 Pending JP2022535743A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201962854288P 2019-05-29 2019-05-29
US62/854,288 2019-05-29
PCT/US2020/035249 WO2020243519A1 (en) 2019-05-29 2020-05-29 Compounds and compositions for treating conditions associated with sting activity

Publications (2)

Publication Number Publication Date
JP2022535743A JP2022535743A (ja) 2022-08-10
JP2022535743A5 true JP2022535743A5 (cg-RX-API-DMAC7.html) 2023-06-01

Family

ID=71787083

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2021570361A Pending JP2022535743A (ja) 2019-05-29 2020-05-29 Sting活性に関連する状態を治療するための化合物および組成物

Country Status (5)

Country Link
US (1) US20220227760A1 (cg-RX-API-DMAC7.html)
EP (1) EP3976584A1 (cg-RX-API-DMAC7.html)
JP (1) JP2022535743A (cg-RX-API-DMAC7.html)
MA (1) MA56047A (cg-RX-API-DMAC7.html)
WO (1) WO2020243519A1 (cg-RX-API-DMAC7.html)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TWI873098B (zh) 2018-07-03 2025-02-21 瑞士商諾華製藥公司 用於治療與sting活性相關之病症的化合物及組合物
US20230141284A1 (en) 2020-04-10 2023-05-11 Ono Pharmaceutical Co., Ltd. Cancer therapeutic method
WO2022133046A2 (en) * 2020-12-16 2022-06-23 Ifm Due, Inc. Compounds and compositions for treating conditions associated with sting activity
US20240051970A1 (en) * 2020-12-16 2024-02-15 Ifm Due, Inc. Compounds and compositions for treating conditions associated with sting activity
JP2024504002A (ja) * 2020-12-22 2024-01-30 アイエフエム デュー インコーポレイテッド がんを処置する方法
JP2024500877A (ja) * 2020-12-22 2024-01-10 アイエフエム デュー インコーポレイテッド がんを処置する方法
US20240122903A1 (en) 2020-12-22 2024-04-18 Ifm Due Inc. Methods of treating cancer
JP2024500874A (ja) 2020-12-22 2024-01-10 アイエフエム デュー インコーポレイテッド がんを処置する方法
JP2024502474A (ja) 2021-01-08 2024-01-19 アイエフエム デュー インコーポレイテッド Sting活性に関連する状態を治療するための、尿素を有するヘテロ二環式化合物または類似体およびその組成物
AU2022326463A1 (en) 2021-08-10 2024-02-22 Novartis Pharma Ag Compounds and compositions for treating conditions associated with sting activity
WO2024064358A1 (en) 2022-09-23 2024-03-28 Ifm Due, Inc. Compounds and compositions for treating conditions associated with sting activity

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2001290912A1 (en) * 2000-09-15 2002-03-26 Vertex Pharmaceuticals Incorporated Pyrazole compounds useful as protein kinase inhibitors
US7927613B2 (en) 2002-02-15 2011-04-19 University Of South Florida Pharmaceutical co-crystal compositions
MY153898A (en) * 2005-06-22 2015-04-15 Plexxikon Inc Compounds and methods for kinase modulation, and indications therefor
KR20130088002A (ko) * 2010-01-13 2013-08-07 재단법인 한국파스퇴르연구소 항-감염성 피리도(1,2-a)피리미딘
WO2012075380A1 (en) 2010-12-03 2012-06-07 The Trustees Of The University Of Pennsylvania Tip60 inhibitors
JP6121658B2 (ja) * 2011-06-29 2017-04-26 大塚製薬株式会社 治療用化合物、及び関連する使用の方法
US9260426B2 (en) * 2012-12-14 2016-02-16 Arrien Pharmaceuticals Llc Substituted 1H-pyrrolo [2, 3-b] pyridine and 1H-pyrazolo [3, 4-b] pyridine derivatives as salt inducible kinase 2 (SIK2) inhibitors
CU24377B1 (es) 2013-05-18 2018-12-05 Aduro Biotech Inc Dinucléotidos de purina cíclicos y composiciones de los mismos útiles para inducir la producción de interferón de tipo i dependientes de sting
AU2014340269B2 (en) 2013-10-21 2018-06-21 Drexel University Use of STING agonists to treat chronic hepatitis B virus infection
US9580430B2 (en) * 2014-02-28 2017-02-28 The Regents Of The University Of Michigan 9H-pyrimido[4,5-B]indoles and related analogs as BET bromodomain inhibitors
EP3632915A1 (en) * 2014-11-27 2020-04-08 Genentech, Inc. 4,5,6,7-tetrahydro-1 h-pyrazolo[4,3-c]pyridin-3-amine compounds as cbp and/or ep300 inhibitors
US12213978B2 (en) * 2018-11-15 2025-02-04 INSERM (Institut National de la Santé et de la Recherche Médicale) Madrasin-derivative compounds, composition and uses thereof for treating cancer
EP3883651A1 (en) * 2018-11-19 2021-09-29 IFM Due, Inc. Compounds and compositions for treating conditions associated with sting activity

Similar Documents

Publication Publication Date Title
JP2023509422A5 (cg-RX-API-DMAC7.html)
WO2023072197A1 (en) Piperidinyl indole derivatives, preparation methods and medicinal uses thereof
JP7128969B2 (ja) Pcsk9阻害剤及びその使用方法
JP6353529B2 (ja) 置換されたテトラヒドロカルバゾールおよびカルバゾールカルボキサミド化合物
JP4890723B2 (ja) TNFαインヒビターとして有用なクマリン誘導体
AU2003258576B2 (en) Pyrrolidinedione substituted piperidine-phthalazones as PDE4 inhibitors
RU2737190C2 (ru) Ингибиторы репликации вируса гриппа, способы их применения и использование
US20080227789A1 (en) Diaminothiazoles useful as axl inhibitors
US6605624B1 (en) Substituted pyridines useful for inhibiting cholesteryl ester transfer protein activity
US20050267114A1 (en) Triazaspiro[5.5]undecane derivatives and drugs comprising the same as the active ingredient
RU2007119784A (ru) Бициклические производные пиримидина, ингибирующие вич
PE20011166A1 (es) Piridinas, pirimidinas, purinonas, pirrolopirimidinonas y pirrolopiridinonas como antagonistas del factor liberador de corticotropina
AR038864A1 (es) Inhibidores pirimidina y piridina biciclicos de la p38 quinasa
JP6353530B2 (ja) キナーゼ阻害剤として有用なカルバゾールカルボキサミド化合物
CZ294603B6 (cs) Deriváty karboxylové kyseliny
AR045260A1 (es) Compuestos que contienen imidazo-oxima sustituidos
RU2008130884A (ru) Гетероциклические ингибиторы янус-киназы 3
RU2008109185A (ru) Получение и применение тетрагидропиролло[3, 2-с]пиридин-4-оновых производных для лечения ожирения, психиатрических и неврологических расстройств
RU2003134371A (ru) Пиразоло [1, 5-а] пиридины и содержащие их лекарственные средства
AU2013277476A1 (en) 1,2,4-triazine-6-carboxamide kinase inhibitors
JP2024502473A5 (cg-RX-API-DMAC7.html)
JP2014528450A (ja) 肝細胞癌を含む癌の阻害剤、および肝炎ウイルス複製の阻害剤としての置換アミノチアゾール
RU2009128968A (ru) Производные изосорбидмононитрата для лечения повышенной внутриглазной гипертензии
AR055431A1 (es) Derivados del acido 4-amino-tieno[3,2-c]piridina-7-carboxilico
CN115873000B (zh) 异喹啉酮类及喹唑啉酮类化合物及其组合物和用途